You are here: Home » Reuters » News
Business Standard

Sanofi in talks to sell generics arm to Advent for $2.4 billion

Reuters  |  PARIS 

PARIS (Reuters) - French healthcare group Sanofi is in exclusive talks to sell its Zentiva European generics drugs arm to private equity firm Advent International for 1.9 billion euros ($2.4 billion), the companies said on Tuesday.Sanofi said the sale was expected to be completed before the end of the year, and Advent's offer was binding and fully financed. The 1.9 billion euros price is an enterprise value, including equity and debt.The planned Zentiva sale follows a move by UK group Shire this week to sell its oncology business to unlisted French drugmaker Servier for $2.4 billion. Sanofi ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Tue, April 17 2018. 13:02 IST